checkAd

     144  0 Kommentare EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock - Seite 3

    Contacts

    Investors:
    Argot Partners
    Kimberly Minarovich or Joe Rayne
    212-600-1902
    eyepoint@argotpartners.com

    Lesen Sie auch

    Media:
    Thomas Gibson
    (201) 476-0322
    tom@tomgibsoncommunications.com


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock - Seite 3 WATERTOWN, Mass., Feb. 21, 2020 (GLOBE NEWSWIRE) - EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products today announced the pricing of an underwritten …